Xtx Topco LTD Horizon Therapeutics Public LTD CO Transaction History

Xtx Topco LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$96.34 - $112.38 $302,218 - $352,536	-3,137 Reduced 41.34%	4,451 $457,000
Q1 2023 May 12, 2023	BUY	$107.32 - $113.5 $814,344 - $861,238	7,588 New	7,588 $828,000
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $259,796 - $380,729	-3,272 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $282,766 - $359,298	3,272 New	3,272 $344,000
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $557,356 - $678,091	-5,655 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $240,160 - $288,396	2,613 Added 85.9%	5,655 $619,000
Q2 2021 Aug 12, 2021	BUY	$86.24 - $95.92 $262,342 - $291,788	3,042 New	3,042 $285,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.